Erasca

+$1.22 (+6.83%) As of 7:47 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Erasca and other ETFs, options, and stocks.

About ERAS

Erasca, Inc. is a clinical stage precision oncology company that focuses on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs.

CEO
Jonathan E. Lim
Employees
—
Headquarters
San Diego, California
Founded
2018

ERAS Key Statistics

Market Cap
2.31B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
398.85K
High Today
$19.31
Low Today
$17.92
Open Price
$17.95
Volume
933.61K
52 Week High
$24.47
52 Week Low
$14.51

ERAS Earnings

-$1.20
-$0.80
-$0.40
$0.00
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure